In this study, we measured a panel of CSF biomarkers, including 42 amino-acid forms of amyloid-β (Aβ42), total tau protein (t-tau), and phosphorylated tau protein (p-tau), to find elements supporting the differential diagnosis between iNPH and other neurodegenerative diseases. Here, MAPT is linked to neurodegenerative disease.